BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 19434856)

  • 1. Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking.
    Oba M; Aoyagi K; Miyata K; Matsumoto Y; Itaka K; Nishiyama N; Yamasaki Y; Koyama H; Kataoka K
    Mol Pharm; 2008; 5(6):1080-92. PubMed ID: 19434856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nordihydroguaiaretic Acid-Cross-Linked Phenylboronic Acid-Functionalized Polyplex Micelles for Anti-angiogenic Gene Therapy of Orthotopic and Metastatic Tumors.
    Hao T; Zhang B; Li W; Yang X; Wu S; Yuan Y; Cui H; Chen Q; Li Z
    ACS Appl Mater Interfaces; 2024 Jun; ():. PubMed ID: 38934519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.
    Zhou QH; You YZ; Wu C; Huang Y; Oupický D
    J Drug Target; 2009 Jun; 17(5):364-73. PubMed ID: 19263264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controllable Star Cationic Poly(Disulfide)s Achieve Genetically Cascade Catalytic Therapy by Delivering Bifunctional Fusion Plasmids.
    Yu D; Wang Y; Qu S; Zhang N; Nie K; Wang J; Huang Y; Sui D; Yu B; Qin M; Xu FJ
    Adv Mater; 2023 Dec; 35(52):e2307190. PubMed ID: 37691439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic genomic nanomedicine with triple-responsiveness for systemic anti-tumor therapy.
    Qin C; Wang H; Cui H; Wang Y; Zhang M; Li H; Liu Y; Wang J; Chen Q; Zhao Y
    J Colloid Interface Sci; 2024 Jun; 672():350-362. PubMed ID: 38850862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminus 4-Chloromethyl Thiazole Peptide as a Macrocyclization Tool in the Synthesis of Cyclic Peptides: Application to the Synthesis of Conformationally Constrained RGD-Containing Integrin Ligands.
    Nefzi A; Fenwick JE
    Tetrahedron Lett; 2011 Feb; 52(7):817-819. PubMed ID: 21423849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-sensitive siRNA-loaded nanobubbles fabrication and antagonism in drug resistance for NSCLC.
    Su C; Ren X; Yang F; Li B; Wu H; Li H; Nie F
    Drug Deliv; 2022 Dec; 29(1):99-110. PubMed ID: 34964410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced in developmental organic and inorganic nanomaterial: a review.
    Khalid K; Tan X; Mohd Zaid HF; Tao Y; Lye Chew C; Chu DT; Lam MK; Ho YC; Lim JW; Chin Wei L
    Bioengineered; 2020 Dec; 11(1):328-355. PubMed ID: 32138595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional nanoassemblies of block copolymers for future cancer therapy.
    Cabral H; Kataoka K
    Sci Technol Adv Mater; 2010 Feb; 11(1):014109. PubMed ID: 27877324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cell-Penetrating Peptide with a Guanidinylethyl Amine Structure Directed to Gene Delivery.
    Oba M; Kato T; Furukawa K; Tanaka M
    Sci Rep; 2016 Jan; 6():19913. PubMed ID: 26814673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures.
    Murugan K; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Int J Nanomedicine; 2015; 10():2191-206. PubMed ID: 25834433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine for gene therapy.
    Alex SM; Sharma CP
    Drug Deliv Transl Res; 2013 Oct; 3(5):437-45. PubMed ID: 25788352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 mediates gene transfer and cytotoxicity of polyethyleneimine in mammalian cell lines.
    Yang HJ; Feng P; Wang L; Li ZC; Ma SP; Wang M; Feng ZW
    Mol Cell Biochem; 2015 Apr; 402(1-2):203-11. PubMed ID: 25626893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation.
    Cheng L; Huang FZ; Cheng LF; Zhu YQ; Hu Q; Li L; Wei L; Chen DW
    Int J Nanomedicine; 2014; 9():921-35. PubMed ID: 24611009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers.
    Li Y; Xiao K; Zhu W; Deng W; Lam KS
    Adv Drug Deliv Rev; 2014 Feb; 66():58-73. PubMed ID: 24060922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Targeting via Integrin Ligands.
    Marelli UK; Rechenmacher F; Sobahi TR; Mas-Moruno C; Kessler H
    Front Oncol; 2013 Aug; 3():222. PubMed ID: 24010121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional hierarchically assembled nanostructures as complex stage-wise dual-delivery systems for coincidental yet differential trafficking of siRNA and paclitaxel.
    Elsabahy M; Shrestha R; Clark C; Taylor S; Leonard J; Wooley KL
    Nano Lett; 2013 May; 13(5):2172-81. PubMed ID: 23574430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibly crosslinked nanocarriers for on-demand drug delivery in cancer treatment.
    Shao Y; Huang W; Shi C; Atkinson ST; Luo J
    Ther Deliv; 2012 Dec; 3(12):1409-27. PubMed ID: 23323559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging.
    Hak S; Helgesen E; Hektoen HH; Huuse EM; Jarzyna PA; Mulder WJ; Haraldseth O; Davies Cde L
    ACS Nano; 2012 Jun; 6(6):5648-58. PubMed ID: 22671719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of a splice-switching oligonucleotide by cationic polyplexes of RGD-oligonucleotide conjugate.
    Ming X; Feng L
    Mol Pharm; 2012 May; 9(5):1502-10. PubMed ID: 22497548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.